The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.
Nicola Hulme
Advertisement
Nicola Hulme is a senior research scientist, Bristol Myers Squibb, UK, nicola.hulme@bms.com
Articles by Nicola Hulme
Advertisement
Latest Updated Articles
Covalidation Strategies to Accelerate Analytical Method Transfer for Breakthrough TherapiesPublished: April 2nd 2017 | Updated:
Advertisement
Advertisement
